Each 1 mg dose of bendamustine hydrochloride chemotherapy given by injection

This code represents the administration of bendamustine hydrochloride, an alkylating agent used in chemotherapy. It is typically employed in the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or after treatment with rituximab or other alkylating agents.

This code is used when bendamustine hydrochloride is administered intravenously to a patient for an oncologic indication. Documentation should clearly specify the drug name, dosage (in milligrams), and the route of administration. It is typically billed in conjunction with an administration code (e.g., CPT 96413, 96415).

• Report units based on 1 mg increments of bendamustine hydrochloride administered.
• Do not confuse with other chemotherapy agents; verify the specific drug name from the physician's order and medication administration record.
• Ensure appropriate chemotherapy administration codes are also reported for the infusion service.